Potent Monoclonal Antibodies Neutralize Omicron Sublineages and Other SARS-CoV-2 Variants

Researchers reported the generation and characterization of two potent human monoclonal antibodies, NA8 and NE12, against the receptor-binding domain of the SARS-CoV-2 spike protein.